Advancement of ultrasound molecular imaging applications requires not only a reduction in size of the ultrasound contrast agents (UCAs) but also a significant improvement in the in vivo stability of the shell-stabilized gas bubble. The transition from first generation to second generation UCAs was marked by an advancement in stability as air was replaced by a hydrophobic gas, such as perfluoropropane and sulfur hexafluoride. Further improvement can be realized by focusing on how well the UCAs shell can retain the encapsulated gas under extreme mechanical deformations. Here we report the next generation of UCAs for which we engineered the shell structure to impart much better stability under repeated prolonged oscillation due to ultrasound, and large changes in shear and turbulence as it circulates within the body. By adapting an architecture with two layers of contrasting elastic properties similar to bacterial cell envelopes, our ultrastable nanobubbles (NBs) withstand continuous in vitro exposure to ultrasound with minimal signal decay and have a significant delay on the onset of in vivo signal decay in kidney, liver, and tumor. Development of ultrastable NBs can potentially expand the role of ultrasound in molecular imaging, theranostics, and drug delivery.
Introduction
With an estimated 2.8 billion imaging procedures done in 2011 worldwide, ultrasound is among the most widely used and safest modalities for visualizing tissues and organs in real-time. 1 Therefore, a slight advancement on ultrasound technology can have a potentially large impact in the medical field. As an alternative to commercially UCAs, nanodroplets, nanovesicles, and NBs have been studied. [2] [3] [4] [5] [6] [7] [8] [9] Of growing interest is the use of NBs as UCAs for cancer detection, tumor characterization, image-guided surgeries and biopsies, as well as theranostics. [10] [11] [12] [13] [14] [15] [16] [17] [18] Clinically-used UCAs (1 -10 µm microbubbles) are limited to intravascular applications due to their larger size. 12 For both bubbles, one of the main limitations is the rapid in vivo signal decay; commercially available microbubble formulations have a signal half-life of under 2 min. [19] [20] [21] [22] Development of stable UCAs has been focused primarily on reducing surface tension, varying membrane components, counteracting Laplace pressure, preventing bubble coalescence, and utilizing hydrophobic gases. 15, [23] [24] [25] [26] [27] Still, most of the UCAs that show extended stability in vitro do not perform as well when continuously insonated or used in vivo because their shell is not designed to endure large deformations. Insonated UCAs undergo fast and extreme oscillations for which gas leaks out during expansion and shell materials shed off during compression. 28, 29 Furthermore, UCAs experience strong shear and turbulence as they circulate within the body. 30, 31 Ultrastable NBs can be designed by engineering the bubble membrane shell to be able to withstand deformations due to ultrasound and flow in vivo.
One particular membrane architecture that has been shown to redistribute stress, dissipate excess energy, and deform without irreversible damage is a bilayer with contrasting elastic properties. Membranes comprised of contrasting elastic properties have been shown to provide synergistic improvement in toughness and resilience against defects, stress, and deformations. [32] [33] [34] In nature, this architecture can be found not only in the bacterial cell envelope, but also apparent in the design of interfaces in mammalian blood vessels, skin, and red blood cells. 35, 36 We hypothesize that adapting this architecture can impart NBs an enhanced capacity to minimize gas leakage and membrane shedding during insonation and therefore provide better persistence as it circulates within the body.
Development of ultrastable NBs can facilitate diagnostic ultrasound imaging of various malignancies by providing more accurate, less transient visualization of tumor vasculature and with appropriate molecular targets, detection of cellular biomarkers. In addition, for molecular imaging, stable echogenic NBs can enable a more reliable extravasation beyond the tumor vasculature. Likewise, for drug delivery, a more robust shell can prevent pre-mature release of loaded drug far from the target sites brought about by the collapse of NBs in circulation. Here, we engineered the membrane of ultrastable NBs to be composed of a compliant phospholipid layer by incorporating propylene glycol (PG), an edge-activator used in ultra-deformable liposomal formulations, and glycerol (Gly), a membrane stiffener known to increase buckling of lipid monolayers (Figure 1a) . [37] [38] [39] [40] [41] The unique interfacial design reduces in vitro signal decay of NBs under continuous exposure to ultrasound of varying strength and pulse repetition frequencies, enabling a substantial improvement in both in vivo half-life and in vivo signal decay onset as compared to a common commercially available UCAs. 
Results and Discussion
NBs containing a perfluoropropane (C3F8) gas core were prepared by dissolution of a phospholipid mixture in PBS solution containing PG and Gly (PG-Gly-PL), followed by activation via amalgamation and isolation by differential centrifugation. 26, 27 To directly compare the effects of the glycerol and propylene glycol we also prepared phospholipid stabilized NBs without glycerol (propylene glycol only (PG-PL)), without propylene glycol (glycerol only (Gly-PL)), or using phospholipids alone (PL) without additives. Cryo-EM images shown in Fig 1b and S2 show a dense C3F8 gas core enclosed by a phospholipid membrane. 42 Particle size distribution and concentration for each NB type were determined through resonant mass measurement capable of distinguishing buoyant and non-buoyant particles (liposomes, micelles, etc). [43] [44] [45] [46] [47] The average diameter of NB was measured to be 274 ± 8 nm, at a concentration of 4.07 x 10 11 ± 3.15 x 10 10 NBs/mL, with no particles larger than 1 µm observed in the population (Figure 1c, 1d, S1 ). Cryoelectron microscopy confirms an average diameter of ~200 nm and reveals the nanobubble membrane and dense C3F8 gas core (Figures 1b and S2) . Aside from NBs, non-buoyant particles were also measured to be 194 ± 3 nm in average diameter and concentration of 6.32 x 10 10 ± 1.58 x 10 10 particles/mL. These non-buoyant particles, which are invisible under ultrasound, were reported to sterically hinder coalescence of UCAs, thereby contributing to their overall stability. 48 NBs in PBS showed a slightly negative charge as measured via zeta potential, with no significant differences among formulations (Table S2) . Although the isolated NBs have similar size, charge, and concentration, analysis of the shell material by X-ray diffraction (XRD) showed an additional broad amorphous peak centered at 2θ = ~10° for PG-PL and PG-Gly-PL (Figure 1e ) suggesting that PG expands the distance between phospholipids from ~4.2 Å to ~10.3 Å at some locations. 49, 50 This is consistent with the reported incorporation of edge-activators such as PG into membranes of ultradeformable liposomes. These ultradeformable liposomes have been reported to deform as they pass through a narrow channel (e.g. skin pore) and reform without disruption of their vesicular structure. 37, 38, [51] [52] [53] [54] Of note, the broad peak centered at 2θ = ~10° is not present for pure components ( Figure S3a ) and no preferred crystalline orientation is observed in 2D XRD ( Figure   S3b The ability of a NB to function as an UCA depends on the acoustic impedance difference between the gas and its surrounding and the nonlinearity of the NB oscillation. [56] [57] [58] Tissues do not exhibit nonlinear scattering of the ultrasound wave, enabling high contrast, which is ideally suited for molecular imaging. Therefore, understanding the nonlinear behavior of NB oscillation can facilitate better parameter optimization for molecular imaging and theranostics. 59 Subharmonic, ultraharmonic, second harmonic, as well as fundamental harmonic oscillations, were observed when single NBs were insonated by a 100% bandwidth 25 MHz ultrasound transducer and pressure amplitude of 300 kPa as shown in Figure 2a . Dilute suspensions of NBs were introduced in PBS, and the scattering of single NBs were recorded following a procedure described elsewhere. 60, 61 PG-PL, with the most flexible shell, shows the largest oscillation amplitude for both fundamental (f) and second harmonic (2f) oscillations. This is consistent with the Marmottant model, which predicts that the backscatter intensity is directly proportional to shell flexibility. [62] [63] [64] In contrast, Gly-PL shows the lowest oscillation amplitude for fundamental and second harmonic, suggesting that it has a stiffer shell than PG-PL. The interaction between Gly and phospholipids has been well-studied experimentally, numerically, and via molecular dynamics. 39, 40, [65] [66] [67] [68] Recently, Terakosolphan, et al. found via molecular dynamics simulation that glycerol preferentially interacts with the phosphate and choline in the headgroup of phospholipids. Furthermore, these are experimentally confirmed via Langmuir pressure-area isotherms, FT-IR spectroscopy, fluorescence-based membrane transition temperature determination, and small angle neutron scattering. 39 Pocivavsek et al., in particular, reported the formation of a 10 Å-thick Gly-enriched vitrified adlayer at the phospholipid/solvent interface as measured by neutron and X-ray reflectivity. 41 In the same study, it was shown that the Gly adlayer stiffens the phospholipid monolayer at the air-water interface enabling its folding/buckling normal to the interface when compressed. This stiffening, caused by inter-and intra-hydrogen bonding with the phospholipid, limits the oscillation of Gly-PL NBs when exposed to ultrasound field. PG-Gly-PL, which has a membrane stiffness between that of PG-PL and Gly-PL, shows intermediate amplitude for both fundamental and second harmonic. Furthermore, the PG-Gly-PL NBs undergo a highly stable oscillation with minimal change in amplitude with time.
Aside from fundamental and second harmonic, subharmonic (f/2) and ultraharmonic (3f/2) signals can also be detected for all samples further confirming the non-linear nature of oscillation of NB.
In vitro echogenicity of a solution of NBs (concentration of 4 x 10 9 NB/mL) relative to a tissue-mimicking agarose phantom ( Figure S4a As stated above, one of the main challenges with current UCAs is rapid signal decay due to dissipation of the gas from the bubble core, which is immensely amplified when the UCAs are continuously oscillating due to ultrasound. To assess bubble in vitro stability under constant insonation, we placed the NB solution in a tissue-mimicking phantom with a narrow channel ( Figure S4b ) and exposed it to ultrasound at varying frame rates and pressures ( Figure S7 and S8).
A narrow channel was specifically used to ensure that the NBs were continuously insonated, in contrast to the typical stability test wherein the NB can move in and out of the ultrasound field ( Figure S4b) . 22, 70 In these experiments, PG-Gly-PL showed the slowest signal decay (Figure 3a, b) and the longest in vitro half-life for all pressures and frame rates (Figure 3c, d) . The synergistic effect of having a bilayer with elastic contrast designed similar to natural membranes enabled the PG-Gly-PL to resist failure under continuous oscillation. We hypothesize that while PG introduces elastic and compliant defects in the shell that absorbs excess energy during compression as demonstrated with XRD in Figure 1d , Gly forms a vitrified adlayer that provides stiffness, limits strain during expansion, and functions as an additional layer resisting gas diffusion. 41, 71, 72 Furthermore, PG-PL has a longer in vitro half-life than Gly-PL suggesting that having a compliant shell imparts better stability under ultrasound than having a stiff shell. For all cases, PL always showed the lowest enhancement and shortest in vitro half-life, likely brought about by its inability to endure oscillating deformations. Interestingly, and similar to prior observations by our group, the equilibrium surface tension appeared to have a lesser influence on the bubble stability in this system as Gly-PL or PG-PL showed the lowest surface tension (but not the highest stability) when measured via pendant drop or rising bubble with perfluoropropane gas, respectively ( Figure S9 ). 26 (Figure 4c and d) . The enhancement of PG-Gly-PL was similar to PG-PL and higher than Gly-PL, but PG-Gly-PL bubbles showed a longer in vivo halflife than both PG-PL and Gly-PL. This indicates that PG-Gly-PL is not only the most stable under continuous ultrasound exposure in vitro, but also at higher temperature, under shear and turbulence in physiological blood flow, and in the presence of macrophages in vivo. In is interesting to note that the circulation time of bubbles without glycerol was shorter than both bubbles formulated with glycerol. This could also be indicative of reduced RES clearance due to the presence of glycerol on the bubble surface, an effect previously explored using liposomes. 75 Furthermore, while Lumason® followed the two-compartment pharmacokinetic model typical for UCAs (Figure 4b) , the NBs followed a logistic behavior wherein the intensity remained at its maximum for some time before it started to decay (in vivo decay onset). 76 The in vivo decay onset (Figure 4e ) of PG-Gly-PL was significantly longer than Lumason® (20x longer), PG-PL, and Gly-PL.
This implies that continuous acquisition of high quality images can be performed in preclinical animal models for over 15 min following only a single bolus injection, which is not possible with Lumason® as its signal immediately decay after reaching the peak. Similar behavior was also observed in the liver despite the presence of stellate macrophages known to efficiently eliminate foreign objects ( Figure S10 ). shows >4-fold increase in coverage with PG-Gly-PL nanobubbles. Expanding the use of ultrasound in these applications could make crucial diagnostic imaging tools significantly more accessible to a broader global population as compared to modalities such as magnetic resonance imaging (MRI) and computed tomography (CT). Colorectal cancer, for example, is the second leading cause of cancer-related deaths for both men and women in the United States, 77 ,78 yet the use of ultrasound for colorectal cancer diagnosis has been essentially abandoned by current guidelines in favor of computed tomography (CT). 79 However, there has been recent interest in assessing colorectal tumor angiogenesis by quantitative contrast-enhanced endoscopic ultrasound. 80 New contrast agents could provide complementary data in this area and eventually lead to a more effective diagnosis.
Conclusions
We have shown that our ultrastable NB (PG-Gly-PL) with membrane structure similar to bacterial cell envelope has minimal signal decay when insonated continuously in vitro, has longer in vivo half-life, and has a delayed onset of in vivo signal decay. Despite having a bilayer structure with contrasting elastic property, the backscattered ultrasound from the ultrastable NB still has nonlinear properties when insonated as a single NB or as population. The enhanced in vivo stability of the ultrastable NB can advance the use of ultrasound in molecular imaging, theranostics, and drug delivery. Compared to Lumason® (FDA-approved UCA) and MicroMarker®, our ultrastable nanobubble is able to more effectively enhance the entire tumor vasculature for an extended duration, making it the ideal potential agent for enabling future molecular imaging applications of ultrasound.
Experimental Section
Preparation and Isolation of NB solution. PG-GLy-PL solution (10 mg/mL) was prepared by first Mixture of glycerol (Gly, Acros Organics) and phosphate buffer solution (0.8 mL, Gibco, pH 7.4) preheated to 80 °C was added to the lipid solution. The resulting solution was sonicated for 10 mins at room temperature. Note that we typically prepared batches of 5 or 10 samples at a time and the amounts were adjusted as such. The solution (1 mL) was transferred to a 3 mL headspace vial, capped with a rubber septum and aluminum seal, and sealed with a vial crimper. Air was manually removed with a 30 mL syringe and was replaced by injecting octafluoropropane (C3F8, Electronic Fluorocarbons, LLC, PA) gas. PG-PL and Gly-PL solutions were prepared similar to PGGly-PL but with 1 mL of PG and 1 mL of Gly, respectively, instead of 0.5 mL of PG and 0.5 mL of
Gly. PL solution was prepared by directly dissolving the phospholipid mixture into 1 mL PBS. After air was replaced by C3F8, the phospholipid solution was activated by mechanical shaking with a VialMix shaker (Bristol-Myers Squibb Medical Imaging Inc., N. Billerica, MA) for 45s. Nanobubbles were isolated from the mixture of foam and microbubbles by centrifugation at 50 rcf for 5 mins with the headspace vial inverted, and the 100 µL NB solution withdrawn from a fixed distance of 5 mm from the bottom with a 21G needle.
Cryo-EM of NBs. Samples of the PG-Gly-PL NBs washed with PBS after isolation at concentrations around 10 10 particles were applied to Quantifoil holey carbon EM grids (R2/2, 400 mesh:EMS).
The EM grids were glow discharged for 30 sec at 15 mA before the sample was applied. 4 μL aliquots of the NB solution were applied to the EM grids and blotted for 6 sec. Following application, the grids were plunge frozen using a Vitrobot. The prepared cryoEM grids were imaged using a ThemoFisher/FEI TecnaiSpirit cryo-transmission electron microscope (operated at 80kV) equipped with a Gatan US4000 CCD camera. Micrographs were collected at 30kX magnification with a defocus range of -2.5 to -3 μm. Crystallinity analysis of NB membrane by x-ray diffractometer (XRD). 1D and 2D X-ray diffraction experiments were performed using a Bruker Discover D8 X-ray diffractometer, with a monochromated X-ray source (used with a Co Kα X-ray tube), configured in point focus mode. was injected via the mouse tail vein. Nonlinear ultrasound imaging was done in VisualSonics Vevo 3100 using MX250 transducer set at 18 MHz, 4% power, 30 dB contrast gain, 28 dB gain, 40 dB dynamic range, 22 frame per second). The entire tumor was then scanned via a 3d motor with respiratory gating at 0.051 mm step size. The 2d slices were reconstructed and analyzed using VevoCQ.
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